{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:41:29Z","timestamp":1790386889753,"version":"4.1.0"},"reference-count":30,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,9,4]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Assessment of circulating autoantibodies represents one of the earliest diagnostic procedures in patients with suspected connective tissue disease (CTD), providing important information for disease diagnosis, identification and prediction of potential clinical manifestations. The purpose of this study was to evaluate the ability of multiparametric assay to correctly classify patients with multiple CTDs and healthy controls (HC), independent of clinical features, and to evaluate whether serological status could identify clusters of patients with similar clinical features.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogren\u2019s syndrome (SjS), undifferentiated connective tissue disease (UCTD), idiopathic inflammatory myopathies (IIM) and HC were enrolled. Serum was tested for 29 autoantibodies. An XGBoost model, exclusively based on autoantibody titres was built and classification accuracy was evaluated. A hierarchical clustering model was subsequently developed and clinical\/laboratory features compared among clusters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>908 subjects were enrolled. The classification model showed a mean accuracy of 60.84\u00b14.05% and a mean area under the receiver operator characteristic curve of 88.99\u00b12.50%, with significant discrepancies among groups. Cluster analysis identified four clusters (CL). CL1 included patients with typical features of SLE. CL2 included most patients with SjS, along with some SLE and UCTD patients with SjS-like features. CL4 included anti-Jo1 patients only. CL3 was the largest and most heterogeneous, including all the remaining subjects, overall characterised by low titre or lower-prevalence autoantibodies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Extended multiparametric autoantibody assay allowed an accurate classification of CTD patients, independently of clinical features. Clustering according to autoantibody titres is able to identify clusters of CTD subjects with similar clinical features, independently of their final diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003365","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:36:00Z","timestamp":1695299760000},"page":"e003365","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-1916","authenticated-orcid":false,"given":"Giacomo","family":"Cafaro","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-2136","authenticated-orcid":false,"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Baldini","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"},{"name":"Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili di Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fioravanti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, Surgery and Neuroscience, Azienda Ospedaliera Universitaria Senese - Policlinico Le Scotte, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fornaro","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Palterer","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Florence, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-4467","authenticated-orcid":false,"given":"Maria","family":"Infantino","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Allergology, San Giovanni di Dio Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Rigon","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Rheumatology, Campus Bio-Medico University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Del Rosso","sequence":"additional","affiliation":[{"name":"Autoimmunity Lab, IRCCS Ospedale San Raffaele, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-575X","authenticated-orcid":false,"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Villalta","sequence":"additional","affiliation":[{"name":"Immunology and Allergology, Santa Maria degli Angeli Hospital, Pordenone, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-6983","authenticated-orcid":false,"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology, Azienda Sanitaria Universitaria Integrata di Udine, Tolmezzo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"2025090313392799000_9.3.e003365.1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","article-title":"Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases","volume":"16","author":"Bossuyt","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025090313392799000_9.3.e003365.2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/diagnostics12030647","article-title":"The past, present, and future in antinuclear antibodies (ANA)","volume":"12","author":"Irure-Ventura","year":"2022","journal-title":"Diagnostics"},{"key":"2025090313392799000_9.3.e003365.3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol"},{"key":"2025090313392799000_9.3.e003365.4","doi-asserted-by":"crossref","first-page":"103184","DOI":"10.1016\/j.autrev.2022.103184","article-title":"Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: a systematic review and meta-analysis","volume":"21","author":"Dyball","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025090313392799000_9.3.e003365.5","doi-asserted-by":"crossref","first-page":"101462","DOI":"10.1016\/j.berh.2019.101462","article-title":"Autoantibodies in connective tissue disease","volume":"34","author":"Mulhearn","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090313392799000_9.3.e003365.6","doi-asserted-by":"crossref","first-page":"112661","DOI":"10.1016\/j.jim.2019.112661","article-title":"Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies","volume":"474","author":"Cavazzana","year":"2019","journal-title":"J Immunol Methods"},{"key":"2025090313392799000_9.3.e003365.7","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.3390\/diagnostics11122246","article-title":"Profiling of myositis specific antibodies and composite scores as an aid in the differential diagnosis of autoimmune myopathies","volume":"11","author":"Mahler","year":"2021","journal-title":"Diagnostics"},{"key":"2025090313392799000_9.3.e003365.8","doi-asserted-by":"crossref","first-page":"103298","DOI":"10.1016\/j.autrev.2023.103298","article-title":"Identifying subsets of patients with undifferentiated connective tissue disease: results from a prospective, real-world experience using particle-based multi-analyte technology","volume":"22","author":"Radin","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025090313392799000_9.3.e003365.9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2021.03.019","article-title":"Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine\/prothrombin and anti-Beta2 glycoprotein I domain and particle-based multi-analyte technology","volume":"202","author":"Radin","year":"2021","journal-title":"Thromb Res"},{"key":"2025090313392799000_9.3.e003365.10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120622","article-title":"Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine\/prothrombin antibodies","volume":"8","author":"Radin","year":"2020","journal-title":"Biomedicines"},{"key":"2025090313392799000_9.3.e003365.11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/rheumatology\/kez092","article-title":"Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy","volume":"58","author":"Richards","year":"2019","journal-title":"Rheumatology"},{"key":"2025090313392799000_9.3.e003365.12","doi-asserted-by":"crossref","first-page":"102641","DOI":"10.1016\/j.autrev.2020.102641","article-title":"Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome","volume":"19","author":"Sciascia","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025090313392799000_9.3.e003365.13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1515\/cclm-2020-0122","article-title":"Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis","volume":"58","author":"Villalta","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"2025090313392799000_9.3.e003365.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-022-02980-x","article-title":"Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases","volume":"24","author":"Bizzaro","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025090313392799000_9.3.e003365.15","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313392799000_9.3.e003365.16","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212382","article-title":"Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025090313392799000_9.3.e003365.17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313392799000_9.3.e003365.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2025090313392799000_9.3.e003365.19","first-page":"615","article-title":"Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria","volume":"17","author":"Mosca","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313392799000_9.3.e003365.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"key":"2025090313392799000_9.3.e003365.21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110619"},{"key":"2025090313392799000_9.3.e003365.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025090313392799000_9.3.e003365.23","doi-asserted-by":"crossref","first-page":"103143","DOI":"10.1016\/j.autrev.2022.103143","article-title":"Seronegative autoimmune diseases: a challenging diagnosis","volume":"21","author":"Lenti","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025090313392799000_9.3.e003365.24","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025090313392799000_9.3.e003365.25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313392799000_9.3.e003365.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200328"},{"key":"2025090313392799000_9.3.e003365.27","first-page":"53","article-title":"Significance of anti-La\/SSB antibodies in primary Sj\u00f6gren\u2019s syndrome patients with combined positivity for anti-Ro\/SSA and salivary gland biopsy","volume":"38 Suppl 126","author":"Cafaro","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313392799000_9.3.e003365.28","first-page":"2373","article-title":"Distinct clinical phenotypes of primary Sj\u00f6gren\u2019s syndrome differ by onset age: a retrospective study of 742 cases and review of the literature","volume":"40","author":"Luo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313392799000_9.3.e003365.29","first-page":"2211","article-title":"Sj\u00f6gren\u2019s syndrome: one year in review 2022","volume":"40","author":"Manfr\u00e8","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313392799000_9.3.e003365.30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001144","article-title":"Clinical spectrum time course in anti Jo-1 positive Antisynthetase syndrome: results from an international retrospective multicenter study","volume":"94","author":"Cavagna","year":"2015","journal-title":"Medicine (Baltimore)"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:39:37Z","timestamp":1756931977000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9,21]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/rmdopen-2023-003365"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003365","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}